![](/img/cover-not-exists.png)
AXL/MET dual inhibitor, CB469, has activity in non-small cell lung cancer with acquired resistance to EGFR TKI with AXL or MET activation
Yang, Yu-Mi, Jang, Yoon, Lee, Sang Hyuk, Kang, Beodeul, Lim, Sun MinJournal:
Lung Cancer
DOI:
10.1016/j.lungcan.2020.05.031
Date:
May, 2020
File:
PDF, 3.76 MB
2020